Plasma Sodium and Sodium Administration in the ICU

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-04

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients in the Intensive Care Unit often present with low levels of plasma sodium and are therefore often administered high amounts of sodium, both as an additive to intravenous glucose solutions and as a constituent of various drugs and infusion fluids. Recent findings question the benefit of these large quantities of sodium and raise the question whether the individual physician takes the total sodium administration into account when sodium additives are prescribed. It can also be suspected that sodium prescription differs significantly between physicians.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients

NCT05085223

Hypernatremia Critical Illness

UNKNOWN

Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit

NCT03752450

Hypernatremia

COMPLETED

Hydrochloorthiazide and Hypernatriaemie

NCT01974739

Hypernatraemia

COMPLETED NA

Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water

NCT06061783

Hypernatremia

UNKNOWN NA

Colloid Osmotic Pressure and Osmolality in Hyponatremia

NCT03703713

Hyponatremia

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Treatment with intravenous fluids (fluid therapy) is a cornerstone in intensive care. The primary aim of fluid therapy is to optimize the amount of fluid in the various spaces of the body: intravascularly (plasma), intracellularly and interstitially. Secondarily, one tries to optimize the constitution of fluid in plasma, since this is the only fluid space that is available for analysis. Fluid constitution is referring to the physical properties such as pH-value, osmolality, and partly the concentration of different elements solved in plasma (i.e. sodium, potassium, chloride, magnesium, and proteins like albumin). For this reason, there are a lot of different fluids that the physician in the intensive care can choose from. In addition, the physician can also choose to prescribe different additives to adapt these fluids to fulfil the individual patient's needs. Therefore, to prescribe both the amount and constituency of fluid therapy is a key task for ICU-physicians.

One of the most important additives to be prescribed is sodium. Sodium is the molecule (except for water) that has the highest concentration in plasma (normally around 140 mmol/L) and is therefore of utmost importance for plasma osmolality. Sodium concentration in plasma is often decreased in critically ill patients (hyponatremia) which, in turn, is associated with a worse outcome, and thus a normal task for an ICU-physician to attempt to regulate through administering amounts of sodium that are substantially higher than the physiological needs.

Recent findings have revealed that there is a large variation between different physicians when it comes to the amount of fluid the patient receives, a variation that has no scientific basis.

Fluids used in the operating room and in the intensive care often contain large quantities of sodium to create a physiological osmolality. It is thus hypothesized that it is not only the large quantities of fluid that causes a worse outcome in fluid overload, but also the un-physiologically large amount of administered sodium.

The aim of the study is partly to gain knowledge about how sodium prescription is performed in clinical practice in the intensive care, as well as how this administration relates to actual changes in plasma sodium.

Statistical method: Normal distribution will be tested via the Shapiro-Wilks test. All tests of significance are performed two-sided. P-value lower than 0.05 is considered significant. No corrections for multiple comparisons are performed if nothing else is stated.

Missing values: Single missing values are principally not replaced. In exceptional cases, if missing data leads to a whole series of data being misleading, then missing data can be imputed by calculating the mean of two adjacent values, under the condition that this results in a reasonable value.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypernatremia Hyponatremia Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult
* Documented length of stay at the Central Intensive Care Unit (CIVA) at the University Hospital of Linköping of seven (7) days minimum.
* The patient has been discharged from the ICU.
* Body Mass Index (BMI) between 18.0 and 48.0 kg/m2 at admission.

Exclusion Criteria

* The patient has previously been included in the study in connection with another ICU-admission.
* The patient has a severe hyponatremia (\<129 mmol/L) upon arrival to the ICU.
* The patient has a severe hypernatremia (\>149 mmol/L) upon arrival to the ICU.
* The patient is severely hyperosmolar (\>330 mmol/L) upon arrival to the ICU.
* The patient is severely hyperglycemic (\>30 mmol/L) upon arrival to the ICU.
* The patient has an elevated serum urea (\>30 mmol/L) upon arrival to the ICU.
* The patient receives any dialysis treatment during the observation time.
* The patient is suspected to have an elevated intracranial pressure during the observation time or is suspected to have other intracranial pathology that is likely to affect sodium homeostasis
* The patient has an intoxication with toxic alcohols as a primary diagnosis.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No